A Once-Daily Lopinavir/Ritonavir-Based Regimen Is Noninferior to Twice-Daily Dosing and Results in Similar Safety and Tolerability in Antiretroviral-Naive Subjects Through 48 Weeks
Gathe, Joseph, da Silva, Barbara A, Cohen, Daniel E, Loutfy, Mona R, Podzamczer, Daniel, Rubio, Rafael, Gibbs, Sara, Marsh, Theresa, Naylor, Christian, Fredrick, Linda, Bernstein, BarryVolume:
50
Language:
english
Journal:
JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI:
10.1097/qai.0b013e31819c2937
Date:
April, 2009
File:
PDF, 437 KB
english, 2009